Condition: Diabetic Macular Edema · Sponsor: Dr. Bryan Strelow
The objectives of this investigation are to assess: 1. whether oral K9 is safe in subjects with DME, and 2. whether oral K9 improves BCVA compared to oral placebo
This description comes directly from the study's public registry record.
Mary Galyen, BS, COA · 826-867-8808 · mgalyen@vistareye.com
Bryan Strelow, MD · 540-855-5100 · bstrelow@vistareye.com
Always discuss trial participation with your own doctor first.
| Vistar Eye Center | Roanoke, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07458061